LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,443 pages found matching data breach- Bextra: The Kind of Pain That Never Leaves You
Apr-1-08 San Francisco, CA Joann Simmons is a name on a court docket now—just two words in a legal document. But those two words represent someone's life partner, who is no longer here. And the life partner left behind, James Simmons, has filed a wrongful death suit against the makers of Bextra. Bextra, a pain medication manufactured by Pfizer, is off... - The Trasylol Tragedy: No Reprisals for Bayer
Mar-31-08 Sarasota, FL If there is a lesson that could be taken from the Trasylol tragedy, it might be that drug makers who hide, avoid, or mistakenly withhold important safety data from public, or even medical consumption would face certain censure in some fashion as an inducement not to ever allow such an oversight to happen again. That lesson, however, has eit... - Springfield school committee pays $35,000 settlement in contract buyout.
Springfield, MA: (Mar-26-08) Quaboag Regional Middle/High School brought a lawsuit against principal C. Stephen Collins, alleging that he altered the grades for a friend's daughter, who needed an additional half-credit to graduate. Collins repeatedly denied the allegations, while claiming he was forced to resign from his post at the school. Records show... - Stock Options: Honesty and Deception Filter Down from the Top
Mar-31-08 New York, NY One needs only to pick up the paper on any given day to read about yet another highly-paid corporate player having his or her way with the system, by thumbing a nose at securities law and manipulating stock options to improve yield and reduce tax. For this reason, any employee of any company who participates in, or has stock options through... - Avandia: Meant to Help but Killed Instead
Mar-30-08 Edmonton, AB Early in August 2006, Vivian's mother went to the hospital in Edmonton to have some cancer tests done. However, when she arrived the doctors noticed that the left side of her body was swollen. They took her vital signs and noticed her heart was racing. She was admitted to hospital that day, and on further testing the doctors discovered that he... - The Duragesic patch: Fentanyl Can Kill More Than Pain...
Mar-29-08 Raritan, NJ: Chronic pain sufferers will tell you that the Duragesic patch is so bad, it's good. Very, very good, in stemming the kind of chronic pain most closely associated with cancer patients, and others who suffer with ailments and agony the rest of us couldn't imagine having to live with. But make no mistake, the Duragesic patch and the opioid t... - New Trasylol Trial Halted Due to Deaths
Mar-29-08 Washington, DC: On March 27, 2008 Bayer AG said that a new trial on Trasylol had to be halted because the risk of death increased due to excessive bleeding. In addition to this new trial, previous studies have shown that Trasylol has a strong link to kidney failure in patients administered the drug when undergoing heart bypass surgery. In 1993, the FDA ap... - Regranex Increases Risk of Death from Cancer
Mar-28-08 Rockville, MD: The Food and Drug Administration (FDA) has announced that it is conducting a safety review based on study data suggesting there may be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel, a skin product used to treat foot, ankle, and leg ulcers. Regranex, approved for U.S. patients in 1997, is... - HIV Drugs Under Suspicion for Increased Risk of Heart Attack
Mar-28-08 Washington, DC In what is fast becoming a never-ending story, a drug that showed no concern in clinical trials is suddenly under the microscope now that the drug is on the market and used by a wider number of Americans. This time it's HIV drugs Ziagen , and Videx , two drugs that have now been identified as posing a greater risk for heart attack tha... - Merck's Singulair: Possible Suicide Link Probed by the FDA
Mar-28-08 Washington, DC Yet another high-profile drug is suddenly under the microscope after reports of suicidal behavior . Singulair , the popular allergy medication marketed by Pharma giant Merck and Co. and raking in sales of $4.3 billion last year, is being scrutinized after what is described as a handful of patient reports have come into the US Food and Dr... - Singulair and Suicide Association under FDA Review
Mar-27-08 Rockville, MD In an "Early Communication" release, the Food and Drug Administration (FDA) informed healthcare professionals and patients of the possible association between the use of Singulair (Montelukast) and behavior/mood changes, suicidality (suicidal thinking) and suicide . The FDA is reviewing Singulair post-marketing reports it has received,... - Former Employee Files $50 Million Suit against CSX
Mar-25-08 Lewisburg, WV: The former president of the Greenbrier, A CSX-owned resort, filed a $50 million lawsuit against the railroad company, alleging that he was unjustly fired by CSX President Michael J. Ward for revealing and trying to put a stop to unethical practices taking place within the company. These unethical practices taking place allegedly involve... - Asbestos Victim Given Last Rites
Mar-25-08 Calgary, AB: On Good Friday, Edgar Blouin was given his last rites at the Peter Lougheed hospital in Calgary. "Edgar started working with his dad when he was only 13," says his step-son Colin MacVicar. "He mixed bags of plaster and the air would be white with asbestos dust. Edgar just turned 64--way too young to die, especially because he was so healthy... - Forever 21 to pay $75,000 settlement in breach of contract lawsuit.
New York, NY: (Mar-21-08) Rootstein, a company that makes realistic mannequins, said to be sculpted by artists, brought a lawsuit against IL based Forever 21, a clothing company, accusing them of making unauthorized copies of their signature mannequins. The suit alleged that in 2007, Forever 21 purchased some of Rootstein's high-quality mannequins, then... - The Tragedy of Trasylol: Did the FDA Stonewall Mangano?
Mar-24-08 Washington, DC The debacle over the handling of Trasylol and the tragedy of thousands of lives lost during the ensuing delay in getting the blood-clotting drug removed from the market, gets more interesting by the day. And once again, the focus turns to a pivotal day in September 2006, during which an advisory committee convened by the US Food and Dru... - Duragesic Patch: Fentanyl is a Cousin to Heroine
Mar-23-08 Atlanta, GA While fentanyl pain patches under the brand name Duragesic and other generics are described as a godsend for people with chronic pain, abuse of the highly potent drug is on the rise, especially by young people. The day before St. Patrick's Day, while many with Irish blood coursing through their veins were getting a head start on the annu... - Pomeroy to pay ex-CEO undisclosed settlement in employment lawsuit.
Hebron, OH: (Mar-17-08) Stephen E. Pomeroy, former President and CEO of Pomeroy IT Solutions, Inc., a provider of IT infrastructure solutions focused on enterprise, network and end-user technologies, brought charges against the company, alleging that it had breached his employment contract when he was wrongly fired. In its defense, Pomeroy IT Solut... - Our Daily Meds: This New Book is an Eye-Opener
Mar-18-08 New York, NY A new book about the pharmaceutical industry slams drug makers, and makes the case for a nation hooked on prescription drugs—which is exactly what Big Pharma wants. Our Daily Meds' - How the Pharmaceutical Companies Transformed Themselves Into Slick Marketing Machines and Hooked the Nation on Prescription Drugs by Melody Petersen is a... - Celebrex Has the Scientists Talking
Mar-17-08 Buffalo, NY In what could hardly be thought of as a celebration, labeling revisions to Celebrex approved by the US Food and Drug Administration this past fall warning of adverse renal function with long-term use , has been augmented by a report coming out of the University of Buffalo (UB) that Celebrex has been shown in laboratory studies to induce irr... - Pasta maker to pay $1.5 million settlement in annual reports fraud lawsuit.
Kansas City, MO: (Mar-16-08) Three lawsuits were brought against American Italian Pasta Co., also naming certain former or current officers and directors, alleging that its executives and directors had misrepresented fiscal data, giving the impression that the company was doing well even as sales slumped during the low-carbohydrate diet craze. Comp...